pharmaphorum

JULY 23, 2019

This pharmaphorum webinar, in association with Tag, will examine the challenges that pharma marketing faces to stay ahead of the evolving customer journey and offer expert insight from both the pharma and FMCG sectors on how to convert these challenges into opportunities.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 7, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q3 2022 having been online for an average of 42.8

84

84

pharmaphorum

MAY 24, 2021

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. The global pandemic stifled many content production shoots and live content creation.

Communication 89

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 89

Pharmaceutical Technology

NOVEMBER 9, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 2.9% in October 2022.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies 69

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Although it has been challenging for some, the types of relationships being built are evolving.

Communication 87

Communication Insurance Packaging Pharmaceutical Companies 87

Roots Analysis

MARCH 1, 2024

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

Packaging 52

Packaging Labelling 52

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. Despite the current popularity of cannabinoid receptors, the regulatory landscape is challenging and complex. This is closely followed by CB2 receptors in second place.

Controlled Substances 98

Controlled Substances Compounding Immunization 98

Pharmaceutical Technology

JULY 6, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 8.2% in June 2022.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

JULY 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q1 2022 having been online for an average of 35.1

59

59

Pharmaceutical Technology

JUNE 27, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 2.8% in May 2022.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

AUGUST 1, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 27, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 18, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.1% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 13, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 11% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 4, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.3% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 23, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in May 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in October 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

SEPTEMBER 21, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.6% in August 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise. .”

Cerner 111

Cerner 111

Pharmaceutical Technology

AUGUST 10, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 3.3% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 3, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 20, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 11, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 4.7% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Communication 114

Communication Documentation Labelling Vaccines 114

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. But while companies continue studying allogeneic CAR-T therapies, including for their coveted use in solid tumours, such advancements remain challenging. We also have the challenge of delivery.

FDA 59

FDA Immunization 59

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Finding solutions.

Insurance 52

Insurance Vaccines 52

pharmaphorum

NOVEMBER 28, 2022

Owkin is committed to unlocking the vast potential held within patient data by developing technologies that overcome the privacy and security challenges that until now impacted research.”. Owkin in particular has bagged some high-profile, high-price tag development deals with the likes of Bristol-Myers Squibb and Sanofi.

Hospitals 72

Hospitals 72

pharmaphorum

JANUARY 11, 2022

Blue Note said the new status recognised the potential of BNT200 for the thousands of patients diagnosed with AML every year in the US who can find it challenging to cope with both the symptoms of the cancer and the debilitating side effects of treatment. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on.

FDA 64

FDA Chemotherapy Hospitals 64

pharmaphorum

NOVEMBER 24, 2022

One issue has been the cost of the drug, with health technology assessment agency NICE in the UK and the ICER organisation in the US both concluding its price tag means it is not a cost-effective option for health systems. and 14.1%, respectively.

Labelling 52

Labelling Hospitals 52

pharmaphorum

DECEMBER 2, 2020

US biotech TG Therapeutics has begun a rolling filing with the FDA for its combination therapy for chronic lymphocytic leukaemia, in a challenge to Roche. The post TG Therapeutics challenges Roche with FDA filing for CLL drug appeared first on. TG said it expects the data submission to be complete in the first half of 2021.

FDA 52

FDA Chemotherapy 52

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. The post How automation can help to address supply chain challenges in pharma appeared first on.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

DiversifyRx

JUNE 23, 2023

A popular one I have heard about is Mailchimp, but I also have heard it is challenging to use. It offers segmentation, tagging, and scheduling capabilities. I like it because… You get email marketing, automation and segmentation capability, advanced tagging, and web forms all in one place. What CRM would you recommend?

52

52

European Pharmaceutical Review

MARCH 1, 2023

The authors explained that these are commonly used for tagging proteins for study or attaching protein drugs to drug-delivering nanoparticles. To create the surface required, the team coated gold nanoparticles with bioconjugates maleimide (MAL) and N -hydroxysuccinimide ester (NHS).

Vaccines 94

Vaccines 94

The Checkup by Singlecare

AUGUST 31, 2023

If any of these drugs prove too challenging to afford every month, ask the prescriber for medical advice about other Type 2 diabetes medications that haven’t been tried yet. How to get Mounjaro without insurance Brand-name prescription drugs are often challenging to squeeze into a budget.

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). The challenge of providing adequate access to the peripheral EU markets is quite evident. Go-to-market strategies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

European Pharmaceutical Review

MAY 11, 2023

2 Treating SMA can be challenging because “early signs can be difficult to recognise, delaying diagnosis and treatment,” according to Dr Tauscher-Wisniewski. What are the challenges in treating conditions such as spinal muscular atrophy? 1 This is assuming a $1M price tag for all gene therapies.

FDA 71

FDA 71